Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

AMVERSIO 1 G POLVO ORAL EFG - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/AMVERSIO 1 G POLVO ORAL EFG

Approved

STANDARD

AMVERSIO 1 G POLVO ORAL EFG

Serb Sa🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jun 24, 2024
Approval ID: fd289cd3f99e21aa
Company: Serb Sa
Type: Standard

Approval Details

Approval Id: fd289cd3f99e21aa
Drug Cima Aemps Name: AMVERSIO 1 G POLVO ORAL EFG
Register Number: 1221640001
Holder Company Name: Serb Sa
Marketing Company Name: Serb Sa
Holder Company Detail Path: /organization/serb-sa
Marketing Company Detail Path: /organization/serb-sa
Authorization Date: 2024-06-24
Dosage Form: POLVO ORAL
Dose: 1 g
Route Of Administration: VÍA ORAL
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Serb Sa
Company Detail Path: /organization/serb-sa

Company Information

Pharmaceutical Company Name: SERB SA
Country Name: Belgium
Website: http://serb.eu

Active Ingredients

BETAINA ANHIDRA

1 g

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jun 24, 2024

Approval ID

fd289cd3f99e21aa

Type

Standard

Back to CIMA-AEMPS Approvals